(Q42980276)

English

Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection

scientific article published on November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection (English)

1 reference

Europe PubMed Central

12 November 2017

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

author name string

Shinya Maekawa

1

1 reference

Europe PubMed Central

12 November 2017

Minoru Sakamoto

2

1 reference

Europe PubMed Central

12 November 2017

Mika Miura

3

1 reference

Europe PubMed Central

12 November 2017

Makoto Kadokura

4

1 reference

Europe PubMed Central

12 November 2017

Ryota Sueki

5

1 reference

Europe PubMed Central

12 November 2017

Kazuki Komase

6

1 reference

Europe PubMed Central

12 November 2017

Hiroko Shindo

7

1 reference

Europe PubMed Central

12 November 2017

Nobutoshi Komatsu

8

1 reference

Europe PubMed Central

12 November 2017

Kuniaki Shindo

9

1 reference

Europe PubMed Central

12 November 2017

Asuka Kanayama

10

1 reference

Europe PubMed Central

12 November 2017

Takako Ohmori

11

1 reference

Europe PubMed Central

12 November 2017

Fumitake Amemiya

12

1 reference

Europe PubMed Central

12 November 2017

Shinichi Takano

13

1 reference

Europe PubMed Central

12 November 2017

Tatsuya Yamaguchi

14

1 reference

Europe PubMed Central

12 November 2017

Yasuhiro Nakayama

15

1 reference

Europe PubMed Central

12 November 2017

Takatoshi Kitamura

16

1 reference

Europe PubMed Central

12 November 2017

Taisuke Inoue

17

1 reference

Europe PubMed Central

12 November 2017

Shunichi Okada

18

1 reference

Europe PubMed Central

12 November 2017

Nobuyuki Enomoto

19

1 reference

Europe PubMed Central

12 November 2017

language of work or name

0 references

publication date

1 November 2012

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

56

1 reference

Europe PubMed Central

12 November 2017

5

1 reference

Europe PubMed Central

12 November 2017

1611-1621

1 reference

Europe PubMed Central

12 November 2017

The global burden of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

The role of triple therapy in HCV genotype 1-experienced patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Impact of asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Contribution of Genome-Wide HCV Genetic Differences to Outcome of Interferon-Based Therapy in Caucasian American and African American Patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

HCV genetic elements determining the early response to peginterferon and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Time-related changes in full-length hepatitis C virus sequences and hepatitis activity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

The lipid droplet is an important organelle for hepatitis C virus production

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Hepatitis C virus NS5A: tales of a promiscuous protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Replication of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Efficient initiation of HCV RNA replication in cell culture

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Regulation of Hepatitis C Virion Production via Phosphorylation of the NS5A Protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Identifiers

10.1002/HEP.25826

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42980276&oldid=2126241354"